Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Panbela Therapeutics Inc. (PBLA) had Return on Tangible Equity of 39.48% for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-7.17M |
|
-- |
|
-- |
|
$7.17M |
|
$-7.17M |
|
$-0.01M |
|
$-7.17M |
|
$-7.17M |
|
$-7.17M |
|
$-7.17M |
|
$-7.17M |
|
$-7.17M |
|
$-7.17M |
|
$-7.17M |
|
4.86M |
|
4.86M |
|
$-1.48 |
|
$-1.48 |
|
| Balance Sheet Financials | |
$5.17M |
|
-- |
|
-- |
|
$5.17M |
|
$20.14M |
|
$3.19M |
|
$3.19M |
|
$23.34M |
|
$-18.17M |
|
$-18.17M |
|
$-18.17M |
|
4.86M |
|
| Cash Flow Statement Financials | |
$-12.49M |
|
$0.78M |
|
$9.28M |
|
$2.58M |
|
$0.14M |
|
$-2.44M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.26 |
|
-- |
|
-- |
|
-0.21 |
|
-0.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.72M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
39.48% |
|
|
Return on Tangible Equity |
39.48% |
-138.78% |
|
47.90% |
|
$-3.74 |
|
$-2.41 |
|
$-2.57 |
|